← Career intelligence
Free · no sign-up · 3,138 priced deals

The deal tape

A precedent transactions set answers one question: what did somebody actually pay for a company like this one. Every row here is a US public target that filed a merger proxy or a going-private statement since 2020, with the offer per share, the premium to the unaffected price and the enterprise value multiples read from the filing itself rather than bought from a feed. Choose a sector, an industry code and a size band, and the quartiles above the list are the answer for that cut.

What it is not. Private-company deals, non-US targets and any transaction where no proxy was required leave nothing to read, so none of them are here. Neither are minority stakes or asset sales. Where a cross-check failed, the row still appears and says why, and it is held out of every median and quartile so one bad reading cannot move a number you would quote.

What this cut was bought at

Each measure counts the readings that survive its own cross-checks. Fewer than 4 is a coincidence, not a market.

MeasureDeals25thMedian75th
EV / LTM EBITDA656.1x9.4x11.7x
EV / LTM revenue790.6x1.0x2.2x
Premium to unaffected price8619%32%52%
Premium to 30-day VWAP810%34%39%

Read the EBITDA multiple against the revenue multiple before you use either. Where they disagree sharply the target was priced on growth rather than earnings, and the EBITDA line is the one that will not survive a second question.

Deals by year of announcement
0901792009: 11 deals, 2 clean on every measure2009112010: 179 deals, 40 clean on every measure20101792011: 164 deals, 92 clean on every measure20111642012: 133 deals, 117 clean on every measure20121332013: 155 deals, 136 clean on every measure20131552014: 98 deals, 85 clean on every measure2014982015: 121 deals, 108 clean on every measure20151212016: 156 deals, 142 clean on every measure20161562017: 120 deals, 109 clean on every measure20171202018: 127 deals, 113 clean on every measure20181272019: 115 deals, 108 clean on every measure20191152020: 87 deals, 73 clean on every measure2020872021: 119 deals, 99 clean on every measure20211192022: 112 deals, 98 clean on every measure20221122023: 108 deals, 86 clean on every measure20231082024: 133 deals, 109 clean on every measure20241332025: 121 deals, 98 clean on every measure20251212026: 62 deals, 52 clean on every measure202662
Clean on every measure In doubt on one measure or both
Median EV / LTM EBITDA by sector
Consumer & Retail: 14.0x median across 9 dealsConsumer & Retail14.0xn=9Financials: 10.7x median across 4 dealsFinancials10.7xn=4Technology: 10.3x median across 11 dealsTechnology10.3xn=11Healthcare: 10.1x median across 9 dealsHealthcare10.1xn=9Energy: 9.4x median across 4 dealsEnergy9.4xn=4Industrials: 9.4x median across 5 dealsIndustrials9.4xn=5Business Services: 7.5x median across 7 dealsBusiness Services7.5xn=7Other: 6.9x median across 6 dealsOther6.9xn=6Real Estate: 3.3x median across 4 dealsReal Estate3.3xn=4
Deals by sector
Technology: 24 dealsTechnology24Financials: 20 dealsFinancials20Healthcare: 19 dealsHealthcare19Consumer & Retail: 14 dealsConsumer & Retail14Business Services: 13 dealsBusiness Services13Industrials: 11 dealsIndustrials11Real Estate: 8 dealsReal Estate8Materials: 6 dealsMaterials6Other: 6 dealsOther6Energy: 5 dealsEnergy5Media & Telecom: 4 dealsMedia & Telecom4Utilities: 3 dealsUtilities3
Deals by buyer type
Financial sponsor: 1 dealsFinancial sponsor1Strategic: 75 dealsStrategic75Management / founder: 0 dealsManagement / founder0Controlling holder: 0 dealsControlling holder0Acquisition vehicle: 0 dealsAcquisition vehicle0Unclassified: 57 dealsUnclassified57
Deals by enterprise value
Under $250m: 71 dealsUnder $250m71$250m to $1bn: 27 deals$250m to $1bn27$1bn to $5bn: 32 deals$1bn to $5bn32$5bn to $20bn: 2 deals$5bn to $20bn2Over $20bn: 1 dealsOver $20bn1Not computed: 0 dealsNot computed0
Deals by industry code
Business Services & Software: 24 dealsBusiness Services & Sof…24Chemicals, Pharmaceuticals & Allied Products: 14 dealsChemicals, Pharmaceutic…14Electronics & Electrical Equipment: 10 dealsElectronics & Electrica…10Depository Institutions: 7 dealsDepository Institutions7Industrial Machinery & Computers: 5 dealsIndustrial Machinery & …5Insurance Carriers: 5 dealsInsurance Carriers5Real Estate: 5 dealsReal Estate5Health Services: 5 dealsHealth Services5Oil & Gas Extraction: 4 dealsOil & Gas Extraction4Instruments, Medical Devices & Optical Goods: 4 dealsInstruments, Medical De…4
TargetAcquirerIndustryEVEV / EBITDAEV / revenuePremiumFiling
AMERICAN CORDILLERA MINING Corp
2012-11-05 (filed) · Public merger · $0.05 a share
Not named in the filing
Unclassified
Materials$0mn.a.n.a.
n.a.
DEFM14C
All cash
Metropolitan Health Networks Inc
2012-11-03 · Public merger · $11.25 a share
Humana Inc.
Strategic
Healthcare$741m8.1x1.0x
4%
DEFM14A
All cash
Premierwest Bancorp
2012-10-29 · Public merger · $1.65 a share
Not named in the filing
Unclassified
Financials-$49mn.a.n.a.
9%
DEFM14A
All cash
Pss World Medical Inc
2012-10-24 · Public merger · $29.00 a share
McKesson Corporation
Strategic
Industrials$1.8bnn.a.0.9x
34%
DEFM14A
All cash
Ancestry.com Inc.
2012-10-21 · Public merger · $32.00 a share
Merger Su
Unclassified
Technology$1.3bn10.3x2.9x
10%
DEFM14A
All cash
Ancestry.com Inc.
2012-10-21 · Take-private · $32.00 a share
Global Generations International Inc.
Strategic
Technology$1.3bn10.3x2.9x
10%
SC 13E3
All cash
Cybex International Inc
2012-10-17 · Public merger · $2.55 a share
UM Holdings, Ltd.
Strategic
Other$63m1.5x0.4x
90%
DEFM14A
All cash
Cybex International Inc
2012-10-17 · Take-private · $2.55 a share
UM Holdings, Ltd.
Strategic
Other$63m1.5x0.4x
90%
SC 13E3
All cash
Cymer Inc
2012-10-16 · Public merger · $20.00 a share
ASML Holding N.V.
Strategic
Industrials$359m4.2x0.6x
n.a.
DEFM14A
All cash
China Executive Education Corp
2012-10-16 (filed) · Take-private · $0.32 a share
Not named in the filing
Unclassified
Consumer & Retail$6mn.a.n.a.
80%
SC 13E3
All cash
Turbosonic Technologies Inc
2012-10-10 · Public merger · $0.21 a share
Not named in the filing
Unclassified
Business Services$3mn.a.0.2x
110%
DEFM14A
All cash
Birch Branch Inc
2012-10-05 (filed) · Take-private · $0.10 a share
Not named in the filing
Unclassified
Real Estate$83mn.a.0.2x
n.a.
SC 13E3
All cash
China Nuokang Bio-Pharmaceutical Inc.
2012-09-27 · Take-private · $0.72 a share
Held out of the multiples: no balance sheet at announcement: EV = equity value
Anglo China
Strategic
Healthcare$115mn.a.n.a.
n.a.
SC 13E3
All cash
Physicians Formula Holdings, Inc.
2012-09-26 · Public merger · $4.90 a share
Markwins International Corporation
Strategic
Materials$69m6.1xn.a.
n.a.
DEFM14A
All cash
Sealy Corp
2012-09-26 · Public merger · $2.20 a share
Tempur-Pedic International Inc.
Strategic
Consumer & Retail$901m8.0xn.a.
n.a.
DEFM14C
All cash
West Coast Bancorp /New/or/
2012-09-25 · Public merger · $23.41 a share
Columbia Banking System, Inc.
Strategic
Financials$356mn.a.n.a.
14%
DEFM14A
All cash
Columbia Banking System, Inc.
2012-09-25 · Public merger · $23.41 a share
West Coast Bancorp
Strategic
Financials$559mn.a.n.a.
14%
DEFM14A
All cash
Heska Corp
2012-09-25 (filed) · Take-private · $8.50 a share
Not named in the filing
Unclassified
Healthcare$38m9.2x0.5x
n.a.
SC 13E3
All cash
Ramtron International Corp
2012-09-18 · Public merger · $3.10 a share
Cypress Semiconductor
Strategic
Technology$115m16.0x1.7x
37%
DEFM14A
All cash
Ditech Networks Inc
2012-09-17 · Public merger · $1.45 a share
Nuance Communications, Inc.
Strategic
Technology$20mn.a.1.2x
79%
DEFM14A
All cash
Helix Biomedix Inc
2012-09-11 (filed) · Take-private · $0.60 a share
Not named in the filing
Unclassified
Healthcare$29mn.a.14.6x
n.a.
SC 13E3
All cash
Medicis Pharmaceutical Corp
2012-09-02 · Public merger · $44.00 a share
Valeant Pharmaceuticals International, Inc.
Strategic
Healthcare$1.7bn10.1x2.3x
39%
DEFM14A
All cash
Taro Pharmaceutical Industries Ltd
2012-08-31 (filed) · Take-private · $39.50 a share
Not named in the filing
Unclassified
Healthcare$1.5bn6.1x2.9x
103%
SC 13E3
All cash
Flagstone Reinsurance Holdings, S.A.
2012-08-30 · Public merger · $2.00 a share
Not named in the filing
Unclassified
Financials$206mn.a.0.8x
19%
DEFM14A
All cash
SeaBright Holdings, Inc.
2012-08-27 · Public merger · $11.11 a share
Not named in the filing
Unclassified
Financials$199mn.a.0.7x
34%
DEFM14A
All cash

How to use a set like this

Cut to the narrowest set that still holds eight or ten deals, then quote the range rather than the median. An interviewer who asks where software takes out will accept a spread and press on a single number, because the single number implies a precision the set does not have. Say which deals sit at each end and why: the top of a range is usually a contested auction or a strategic buyer with synergies, the bottom a controlling holder buying in the minority.

Premiums move with the reference price, not only with the deal. A bidder quotes the period that flatters the offer, so read the premium to the unaffected close beside the premium to the thirty-day average and notice when they diverge.

What each column means

Enterprise value.
Offer per share times shares outstanding, plus net debt at the last balance sheet before the merger agreement. It is blank where either piece was missing, and those rows are in the “not computed” band rather than in a size they never earned.
Premium.
The offer against the unaffected price, which is the last close before the deal became known. Where the filing states a premium to the thirty-day volume-weighted average, that is shown next to it.
Deal type.
A take-private is bought by an affiliate, which is what triggers the Schedule 13E-3 and the fuller disclosure that comes with it. A public merger is an arm’s-length buyer, disclosed through the merger proxy.
In doubt.
A cross-check the reading could not satisfy: an equity value far from the fee-table figure, a multiple outside any sane band, or consideration that is partly stock so the per-share cash figure is not the price. The row stays visible, and it is set aside only for the measures the doubt reaches. A cash-and-stock deal cannot price a multiple and still states a premium the filing itself computed, so it counts in one and not the other.

Company names, tickers and logos are the trademarks of their respective owners and appear here to identify the company whose public figures are being used. L3VLUP is not affiliated with, sponsored by or endorsed by any company shown, and nothing here is a statement by or about that company. More